A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation
Clinical trial NCT04176393 · COMPLETED
Trial details
- NCT number
- NCT04176393
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-12
- Primary completion
- 2021-02-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.